“2024 Market Outlook: SmallCap Radar Stocks Unve
Post# of 99103
(Total Views: 102)
Posted On: 12/28/2023 9:15:25 AM
“2024 Market Outlook: SmallCap Radar Stocks Unveiled”: DYAI, SKYX, QUBT, KNW, VTAK
https://thestreetreports.com/2024-market-outl...-knw-vtak/
As the prospect of another new year approaches, a significant number of investors are directing their attention towards potential investment themes within the small-cap sector for 2024. Highlighted at the 12th Annual Benchmark Discovery Conference, held at the New York Athletic Club in December 2023, here are five (5) small-cap stocks noteworthy investment ideas.
Dyadic International Inc. (NASDAQ: DYAI) has garnered attention among institutional investors, with certain stocks being exclusively highlighted. Notably, Dyadic was spotlighted as a top pick at the 12th Annual Benchmark Discovery Conference. This biotech firm is actively engaged in developing a diverse range of products spanning animal health, human health, and alternative proteins. The company is currently leveraging its patented C1 technology in the creation of antibodies and vaccines for various infectious diseases affecting humans. Dyadic is actively working on developing vaccines for other infectious diseases such as influenza and cancer.
Furthermore, Dyadic’s alternative protein initiative is focused on reducing the costs associated with recombinant protein production. Utilizing its Dapibus™ platform and other cutting-edge technologies, the company aims to achieve cost efficiency in producing recombinant non-pharmaceutical proteins. The overarching goal is to advance innovation in the field of protein production.
Remarkably, the stock has experienced a 100% surge in its daily trading volume in the last week. This consolidation may be indicative of a potential shift toward an upward trend, especially when it surpasses its 50-day moving average (DMA).Top of Form
SKYX Platforms Corp. (NASDAQ: SKYX): A pioneering platform technology company, SKYX currently possesses 77 patents globally, with an additional portfolio comprising over 60 home décor and lighting websites. The company’s overarching goal is to enhance the intelligence and safety of buildings and homes.
On December 11, SKYX Platforms Corp. announced the successful renewal of a five-year global licensing master service agreement with GE Technology Development Inc. Under this agreement, the company’s cutting-edge smart technologies will be licensed both in the United States and internationally. The terms of the agreement include provisions for one-year renewals. Notably, the stock has demonstrated a 5% increase in value over the past week.
Know Labs Inc. (NYSEAMERICAN: KNW): This emerging developer of non-invasive medical diagnostic technology unveiled its financial results for the fourth fiscal quarter and the fiscal year concluding on September 30, 2023, on December 19, 2023.
In the 2023 fiscal year, Know Labs Inc. experienced a net loss of $15.29 million, showcasing a notable improvement of 23.8% compared to the net loss of $20.07 million incurred in the 2022 fiscal year. The company reported cash and cash equivalents of $8.02 million at the end of the period, contrasting with $12.59 million at the conclusion of the previous fiscal year. Significantly, the stock has demonstrated a 5% increase in value over the past month.
Catheter Precision, Inc. (NYSE American: VTAK) released its financials and highlights for the Second Quarter of 2023, unveiling total assets amounting to $35.5 million and cash reserves of $7.4 million and revenues for the six-month period ending on June 30, 2023. Catheter Precision, Inc., is a U.S.-based medical device company, offering innovative solutions to enhance the treatment of cardiac arrhythmias. The company collaborates with physicians to develop cutting-edge technology for electrophysiology procedures, and it consistently focuses on enhancing its product offerings.
Recently, the stock has experienced a notable surge in the daily trading volume in recent days. Specifically, during the latter part of December, the trading volume for Catheter Precision Inc. stock increased by approximately 100%.
Quantum Computing Inc. (NASDAQ: QUBT): The technology company specializing in advanced nanophotonics and quantum optics drew attention on November 13 when it disclosed its financial results for the three- and nine-month periods concluding on September 30, 2023.
During the third quarter, Quantum Computing Inc. recorded revenues of $50,000, marking an increase from $38,000 in the same quarter of the previous year and $112,000 in the second quarter of 2023. The cumulative revenues for the first nine months of the year amounted to $283,000, reflecting a notable year-on-year improvement of 111%. It was highlighted that quantum computing had recently entered its commercialization stage. Significantly, the stock has demonstrated a 6% increase in value over the past week.
https://thestreetreports.com/2024-market-outl...-knw-vtak/
As the prospect of another new year approaches, a significant number of investors are directing their attention towards potential investment themes within the small-cap sector for 2024. Highlighted at the 12th Annual Benchmark Discovery Conference, held at the New York Athletic Club in December 2023, here are five (5) small-cap stocks noteworthy investment ideas.
Dyadic International Inc. (NASDAQ: DYAI) has garnered attention among institutional investors, with certain stocks being exclusively highlighted. Notably, Dyadic was spotlighted as a top pick at the 12th Annual Benchmark Discovery Conference. This biotech firm is actively engaged in developing a diverse range of products spanning animal health, human health, and alternative proteins. The company is currently leveraging its patented C1 technology in the creation of antibodies and vaccines for various infectious diseases affecting humans. Dyadic is actively working on developing vaccines for other infectious diseases such as influenza and cancer.
Furthermore, Dyadic’s alternative protein initiative is focused on reducing the costs associated with recombinant protein production. Utilizing its Dapibus™ platform and other cutting-edge technologies, the company aims to achieve cost efficiency in producing recombinant non-pharmaceutical proteins. The overarching goal is to advance innovation in the field of protein production.
Remarkably, the stock has experienced a 100% surge in its daily trading volume in the last week. This consolidation may be indicative of a potential shift toward an upward trend, especially when it surpasses its 50-day moving average (DMA).Top of Form
SKYX Platforms Corp. (NASDAQ: SKYX): A pioneering platform technology company, SKYX currently possesses 77 patents globally, with an additional portfolio comprising over 60 home décor and lighting websites. The company’s overarching goal is to enhance the intelligence and safety of buildings and homes.
On December 11, SKYX Platforms Corp. announced the successful renewal of a five-year global licensing master service agreement with GE Technology Development Inc. Under this agreement, the company’s cutting-edge smart technologies will be licensed both in the United States and internationally. The terms of the agreement include provisions for one-year renewals. Notably, the stock has demonstrated a 5% increase in value over the past week.
Know Labs Inc. (NYSEAMERICAN: KNW): This emerging developer of non-invasive medical diagnostic technology unveiled its financial results for the fourth fiscal quarter and the fiscal year concluding on September 30, 2023, on December 19, 2023.
In the 2023 fiscal year, Know Labs Inc. experienced a net loss of $15.29 million, showcasing a notable improvement of 23.8% compared to the net loss of $20.07 million incurred in the 2022 fiscal year. The company reported cash and cash equivalents of $8.02 million at the end of the period, contrasting with $12.59 million at the conclusion of the previous fiscal year. Significantly, the stock has demonstrated a 5% increase in value over the past month.
Catheter Precision, Inc. (NYSE American: VTAK) released its financials and highlights for the Second Quarter of 2023, unveiling total assets amounting to $35.5 million and cash reserves of $7.4 million and revenues for the six-month period ending on June 30, 2023. Catheter Precision, Inc., is a U.S.-based medical device company, offering innovative solutions to enhance the treatment of cardiac arrhythmias. The company collaborates with physicians to develop cutting-edge technology for electrophysiology procedures, and it consistently focuses on enhancing its product offerings.
Recently, the stock has experienced a notable surge in the daily trading volume in recent days. Specifically, during the latter part of December, the trading volume for Catheter Precision Inc. stock increased by approximately 100%.
Quantum Computing Inc. (NASDAQ: QUBT): The technology company specializing in advanced nanophotonics and quantum optics drew attention on November 13 when it disclosed its financial results for the three- and nine-month periods concluding on September 30, 2023.
During the third quarter, Quantum Computing Inc. recorded revenues of $50,000, marking an increase from $38,000 in the same quarter of the previous year and $112,000 in the second quarter of 2023. The cumulative revenues for the first nine months of the year amounted to $283,000, reflecting a notable year-on-year improvement of 111%. It was highlighted that quantum computing had recently entered its commercialization stage. Significantly, the stock has demonstrated a 6% increase in value over the past week.
(0)
(0)